Full-Time

Engineer – Process Development

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Compensation Overview

$80k - $100kAnnually

Mid

Menlo Park, CA, USA

Position requires onsite presence in Menlo Park, CA.

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD, MSc in Chemical Engineering, Biotechnology, or related field; candidates with Master’s or Bachelor’s degree will be considered with additional experience
  • 2-6 years of experience (depending on education) in process sciences or manufacturing
  • Experience with commercial biologic (e.g., antibody, recombinant protein) processes; cell/gene therapy experience preferred
  • Experience with aseptic techniques and closed manufacturing systems
  • Experience with late-stage process development, including process characterization and/or process validation preferred
  • Experience with regulatory (e.g., IND, BLA) authoring
  • Experience with quality risk management (i.e., risk assessments)
  • Ability to travel to Sacramento occasionally (10 – 20%)
Responsibilities
  • Lead projects to optimize and implement process improvements related to closed and single-use cell therapy manufacture for pre-commercial and post-commercial manufacturing processes
  • Coordinate implementation of process improvements and new process technology into clinical and commercial GMP facilities
  • Play a lead role for core activities during technology transfer of processes into GMP clinical and commercial manufacturing, including on-floor support as Person-In-Plant and authoring and reviewing of technical documents
  • Contribute to process characterization and process validation work packages to progress the CMC development of Orca’s clinical pipeline
  • Author and review plans, protocols, technical reports and CMC sections of regulatory submissions
  • Generate risk assessments and use quality risk management techniques to guide development efforts
  • Collaborate with external vendors and internal engineering teams to design and implement novel automation and closed processing technologies for cell therapy production
  • Participate in investigations and troubleshooting of both manufacturing issues and lab studies

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company aims to enhance these therapies to make them safer and more effective, ultimately improving patient outcomes. Orca Bio's products are designed for healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to advance cell therapy treatments, addressing conditions that currently have limited effective options.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

11%

1 year growth

16%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca Bio's promising clinical data, including high relapse-free survival rates, highlight the potential for curative treatments in challenging patient groups.
  • The company's participation in prestigious conferences like the J.P. Morgan Healthcare Conference and the American Society of Hematology Annual Meeting underscores its industry recognition and thought leadership.
  • Orca Bio's strong team culture and commitment to employee value make it an attractive workplace for talented individuals in the biotechnology field.

What critics are saying

  • The competitive landscape in cell therapy and biotechnology requires continuous innovation to maintain a leading position.
  • Clinical trials and regulatory approvals are inherently risky and can lead to delays or failures, impacting the company's progress and financial stability.

What makes Orca Bio unique

  • Orca Bio's focus on high-precision cell therapies for cancer, autoimmune diseases, and genetic blood disorders sets it apart in the biotechnology sector.
  • Their proprietary single-cell precision manufacturing platform offers uniquely-defined products that aim to transform allogeneic cell therapy.
  • Orca Bio's investigational therapies, such as Orca-T and Orca-Q, demonstrate significantly better outcomes with fewer risks compared to standard treatments.

Help us improve and share your feedback! Did you find this helpful?